$KURA Kura Oncology, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Kura Oncology, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Kura Oncology, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Kura Oncology, Inc. for free.

CIK Number: 0001422143
IRS Number: 611547851
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KURA
Company Address: 3033 SCIENCE PARK ROAD, SUITE 220 SAN DIEGO 92121
Phone number: (858) 500-8800
Former name: ZETA ACQUISITION CORP III, date of change: 2007-12-27

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Market Capitalization: $124.74M
Prev close: $6.20
Average Daily Volume: 27,332
Days Low: $6.20
Year Low: $2.50
Year High: $7.24

Kura Oncology, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
FARNAM JOHNChief Operating Officer00Jan 24 20193 months ago
GRASSO MARCCFO, CBO00Jan 24 20193 months ago
GUALBERTO ANTONIOHead of Development & CMO00Jan 24 20193 months ago
North AnnetteSVP, General Counsel00Jan 24 20193 months ago
REN PINGDASVP Chemistry&Pharma Sciences00Jan 24 20193 months ago
WILSON TROY EDWARDPresident and CEO59,026365,961shares bought: 54,026 / shares sold: 0 STRONG BUYJan 24 20193 months ago

View all Kura Oncology, Inc. insiders.

Kura Oncology, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 24 2019KURAKura Oncology, Inc ...REN PINGDASVP Chemistry&Pharm ...Option ExerciseA15.4775,0001,160,25075,000
Jan 24 2019KURAKura Oncology, Inc ...North AnnetteSVP, General Counse ...Option ExerciseA15.47100,0001,547,000100,000
Jan 24 2019KURAKura Oncology, Inc ...FARNAM JOHNChief Operating Off ...Option ExerciseA15.47125,0001,933,750125,000
Jan 24 2019KURAKura Oncology, Inc ...GRASSO MARCCFO, CBOOption ExerciseA15.47140,0002,165,800140,000
Jan 24 2019KURAKura Oncology, Inc ...GUALBERTO ANTONIOHead of Development ...Option ExerciseA15.47140,0002,165,800140,000
Jan 24 2019KURAKura Oncology, Inc ...WILSON TROY EDWARDPresident and CEOOption ExerciseA15.47220,0003,403,400220,000
Jan 10 2019KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerBuyP13.1683,5401,099,3864,408,0974.3 M to 4.4 M (+1.93 %)
Jan 10 2019KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerBuyP13.8451,879718,0054,324,5574.3 M to 4.3 M (+1.21 %)
Jan 10 2019KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerBuyP13.8278,4691,084,4424,272,6784.2 M to 4.3 M (+1.87 %)
Jan 10 2019KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerSellS13.2026,520350,0644,194,2094.2 M to 4.2 M (-0.63 %)
Dec 13 2018KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerBuyP13.8925,217350,2644,220,7294.2 M to 4.2 M (+0.60 %)
Dec 13 2018KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerBuyP13.9115,321213,0984,195,5124.2 M to 4.2 M (+0.37 %)
Dec 06 2018KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerBuyP13.4917,079230,3964,180,9194.2 M to 4.2 M (+0.41 %)
Dec 06 2018KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerBuyP13.0854,645714,7574,163,1124.1 M to 4.2 M (+1.33 %)
Dec 06 2018KURAKura Oncology, Inc ...EcoR1 Capital Fund Qualified, ...10% OwnerBuyP13.9748,182673,1034,108,4674.1 M to 4.1 M (+1.19 %)

View all Kura Oncology, Inc. insider transactions.